High insulinlike growth factor i is associated with cognitive decline in huntington disease

Neurology

Volumn 76, Issue 7, 2011, Pages 675-676

  Aziz, N Ahmad ^a   Van Der Burg, Jorien M M ^a   Roos, Raymund A C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HUNTINGTIN; SOMATOMEDIN C; SOMATOSTATIN;

COGNITIVE DEFECT; COHORT ANALYSIS; DISABILITY; DISEASE COURSE; DISEASE SEVERITY; FUNCTIONAL DISEASE; GROWTH HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; HUNTINGTON CHOREA; IN VITRO STUDY; IN VIVO STUDY; LETTER; MOTOR DYSFUNCTION; NERVE CELL; NEUROPROTECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WILD TYPE;

COGNITION DISORDERS; HUMANS; HUNTINGTON DISEASE; INSULIN-LIKE GROWTH FACTOR I;

EID: 79951648217     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181fe74ba     Document Type: Letter

References (8)

1. Saleh N, Moutereau S, Azulay JP, et al. High insulinlike growth factor I is associated with cognitive decline in Hun-tington disease. Neurology 2010;75:57-63.
2. Arwert LI, Deijen JB, Drent ML. The relation between insulinlike growth factor I levels and cognition in healthy elderly: a meta-analysis. Growth Horm IGF Res 2005;15:416-422. (Pubitemid 41683810)
3. Aziz NA, Pijl H, Frolich M, et al. Growth hormone and ghrelin secretion are associated with clinical severity in Huntington's disease. Eur J Neurol 2010;17:280-288.
4. Pouladi MA, Xie Y, Skotte NH, et al. Full-length hunting-tin levels modulate body weight by influencing insulin-like growth factor 1 expression. Hum Mol Genet 2010;19: 1528-1538.
5. Trejo JL, Carro E, Garcia-Galloway E, Torres-Aleman I. Role of insulin-like growth factor I signaling in neurode-generative diseases. J Mol Med 2004;82:156-162. (Pubitemid 38392165)
6. Saleh N, Moutereau S, Durr A, et al. Neuroendocrine disturbances in Huntington's disease. PLoS One 2009;4: e4962.
7. Cohen E, Dillin A. The insulin paradox: aging, proteotox-icity and neurodegeneration. Nat Rev Neurosci 2008;9: 759-767.
8. Escartin C, Boyer F, Bemelmans AP, Hantraye P, Brouillet E. IGFI exacerbates the neurotoxicity of the mitochondrial inhibitor 3NP in rats. Neurosci Lett 2007;425:167-172. (Pubitemid 47432722)